Articles

Identification of PIKfyve kinase as a target in multiple myeloma

Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Nanosyn Inc., Santa Clara, CA, USA
Nanosyn Inc., Santa Clara, CA, USA
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2019.222729